TFPI2 and goblet cell carcinoma: In this study, we explored the feasibility of DNA methylation for detection of GCC, and established a new assay, the ColoCaller test, which combined the detection of SDC2, TFPI2, WIF1, and NDRG4 methylation, and evaluated its clinical performance for early detection of GCC.